Ad
related to: 1950 drug causing birth defects in 50sbirthlawyer.sokolovelaw.com has been visited by 10K+ users in the past month
- File a Lawsuit
File in a Timely Manner.
Statute of Limitations May Apply
- Other Birth Injuries
You deserve answers. Call us 24/7
Helping Families for more than 40yr
- Contact Us Now
Free consultations
No fee unless you win
- Why Sokolove Law?
Over 40+ Yrs of Experience
Recovered Over $672M For Families
- About Our Successes
40+ years of experience
Let us help your family
- Request Information
Talk to us 24/7
We can help
- File a Lawsuit
Search results
Results From The WOW.Com Content Network
Grünenthal paid another €50 million into the foundation in 2008. On 31 August 2012, Grünenthal chief executive Harald F. Stock — who served as the chief executive officer of Grünenthal GmbH from January 2009 to May 28, 2013 — apologized for the first time for producing the drug and remaining silent about the birth defects. [48]
Thalidomide is a known human teratogen and carries an extremely high risk of severe, life-threatening birth defects if administered or taken during pregnancy. [6] It causes skeletal deformities such as amelia (absence of legs and/or arms), absence of bones, and phocomelia (malformation of the limbs).
DES gained notoriety when it was shown to cause a rare vaginal tumor in girls and young women who had been exposed to this drug in utero.In 1971, the New England Journal of Medicine published a report showing that seven of eight girls and young women (ages 14 to 22) who had been diagnosed with vaginal clear cell adenocarcinoma had been exposed prenatally to DES. [5]
Thalidomide was used as treatment for cancers, leprosy and HIV, however, the drug was extensively used for the treatment of nausea in pregnant women in the late 1950s and early 1960s until it became apparent in the 1960s that it resulted in severe birth defects.
For premium support please call: 800-290-4726 more ways to reach us
McBride published a letter in The Lancet, in December 1961, noting a large number of birth defects in children of patients who were prescribed thalidomide, [9] after a midwife named Sister Pat Sparrow first suspected the drug was causing birth defects in the babies of patients under his care at Crown Street Women's Hospital in Sydney. [10]
For premium support please call: 800-290-4726 more ways to reach us
Frances Kathleen Oldham Kelsey CM (née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American [1] pharmacologist and physician. As a reviewer for the U.S. Food and Drug Administration (FDA), she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. [2]
Ad
related to: 1950 drug causing birth defects in 50sbirthlawyer.sokolovelaw.com has been visited by 10K+ users in the past month